Top compounds associated with response to GGTLC3


Feature Type Standardized
Nominal ANOVA
mRNA YL54 CTRPv2 pan-cancer AAC 0.017 0.7
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.015 0.7
mRNA VER-155008 CTRPv2 pan-cancer AAC -0.016 0.7
mRNA CBB-1007 CTRPv2 pan-cancer AAC -0.024 0.7
mRNA Bortezomib CTRPv2 pan-cancer AAC -0.015 0.7
mRNA BIX-01294 CTRPv2 pan-cancer AAC 0.015 0.7
mRNA dacarbazine CTRPv2 pan-cancer AAC 0.013 0.7
mRNA BRD-K51831558 CTRPv2 pan-cancer AAC 0.023 0.7
mRNA bafilomycin A1 CTRPv2 pan-cancer AAC -0.064 0.7
mRNA SB-431542 CTRPv2 pan-cancer AAC -0.016 0.7
Download CSV